Table 2 Background characteristics at baseline for infants randomized to BCG or no intervention in the assessment of T and B cell subsets.

From: Effects of Bacillus Calmette-Guérin (BCG) vaccination at birth on T and B lymphocyte subsets: Results from a clinical randomized trial

Enrollment

BCG

No BCG

p value

n = 56

n = 62

Age at randomizationa

   

0–1 days

32(57%)

41(66%)

0.32

2–7 days

24(43%)

21(34%)

 

Male sexa

29 (52%)

32 (52%)

0.99

Gestational age (weeks)b

40 (38–41)

40 (38–41)

0.85

Weight (kg)b

3.5 (3.0–4.0)

3.5 (2.8–4.0)

0.21

Caesarean sectiona

7 (13%)

15 (24%)

0.10

Maternal BCGa

13 (24%)

9 (15%)

0.21

Parental etnicity different from Danisha

8 (14%)

11 (18%) [1]

0.58

Maternal smoking during pregnancya

3(5%)

5 (8%) [1]

0.56

Level of maternal educationa

[1]

 

0.56

Basic schooling and non-theoretical education

10 (18%)

14(23%)

 

Theoretical education incl BA level

28 (51%)

25(41%)

 

Master level or more

17 (31%)

22 (36%)

 

Siblingsa

19 (34%)

21 (34%)

0.99

Atopic predispositionC

39 (70%)

39(63%)

0.44

Lymphocytes (10^9/L) 4 days

5.5

5.3

0.43

Lymphocytes (10^9/L) 3 months

5.6

5.8

0.51

Lymphocytes (10^9/L) 13 months

5.7

6.0

0.40

Lost to follow-upa

2(4%)

10(16%)

0.04

  1. aNumber(Frequency) [missing].
  2. bMedian (10–90 percentiles) [missing].
  3. cAtopic disposition is defined as at least one first degree relative with atopic disease. Atopic disease is defined as physician-diagnosed atopic eczema, asthma, allergic rhinoconjunctivitis or food allergy.